16 October 2017 - They are the breakthrough medicines turning cancer from a death sentence into a chronic disease but only one in five of the Australians who need them are getting them.
High cost immunotherapy treatments that use the body’s own immune system to fight cancer are being used by just 1500 of the 7500 cancer patients who could benefit according to a new report.
Patients, cancer groups, clinicians and pharmaceutical companies will today meet politicians in Canberra to call for changes to Australia’s regulatory and medical subsidy schemes to fast track access to the medicines.